PSYCH INVESTOR SUMMIT: RESEARCH & DEVELOPMENT

Join us on 7 July, 2021 for another global psychedelics industry event. Through our concise half-day programme, we will be showcasing the latest research and development in this exciting sector, alongside expanding businesses looking for capital – delivering the industry’s most promising opportunities directly to investors & funds.

Every PSYCH Investor Summit is an opportunity to engage with distinguished industry leaders, rising entrepreneurs and global psychedelics investors to share insights and help develop this emerging frontier.

Speakers:
Rick Doblin (Founder and Executive Director, MAPS)
Christian Angermayer (Founder, atai Life Sciences)
Dr. Ben Sessa (Chief Medical Officer, Awakn Life Sciences)
Plus many more TBA

For Sponsorship & Media enquires contact our team